1. Home
  2. KFRC vs NMRA Comparison

KFRC vs NMRA Comparison

Compare KFRC & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$30.96

Market Cap

470.6M

ML Signal

HOLD

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$1.81

Market Cap

424.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
NMRA
Founded
1962
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
470.6M
424.4M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
KFRC
NMRA
Price
$30.96
$1.81
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$34.75
$8.00
AVG Volume (30 Days)
251.2K
946.8K
Earning Date
02-02-2026
11-06-2025
Dividend Yield
5.03%
N/A
EPS Growth
N/A
N/A
EPS
2.26
N/A
Revenue
$1,340,771,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$0.61
52 Week High
$57.60
$11.57

Technical Indicators

Market Signals
Indicator
KFRC
NMRA
Relative Strength Index (RSI) 55.55 37.78
Support Level $30.37 $1.69
Resistance Level $31.75 $1.93
Average True Range (ATR) 0.98 0.12
MACD -0.00 -0.03
Stochastic Oscillator 65.09 20.97

Price Performance

Historical Comparison
KFRC
NMRA

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: